Inici › Atrofia muscular espinal › Texas
Assaigs clínics de Atrofia muscular espinal a Texas
10 estudis de Atrofia muscular espinal busquen participants en centres de Texas.
Ciutats de Texas
Text oficial de l'estudi (anglès)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
- The University of Texas Southwestern Medical Center at Dallas, Dallas
- Cook Children's Jane and John Justin Neurosciences Center, Fort Worth
ReclutantFase 4
3 Months – 24 Months · Tots els sexes · Actualitzat el 2 d’oct. 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- University of Texas Southwestern Medical Center, Dallas
- Neurology Rare Disease Center, Flower Mound
- Cook Children's Medical Center, Fort Worth
- i 1 més
ReclutantFase 2
Fins a 2 anys · Tots els sexes · Actualitzat el 2 d’oct. 2026 · NCT07047144A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
- Neurology Rare Disease Center, Flower Mound
- Texas Children's Hospital, Houston
ReclutantFase 2
Edats de 5 a 17 · Tots els sexes · Actualitzat el 14 de set. 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
- University of Texas Southwestern Medical Center, Dallas
ReclutantFase 4
3 Months – 24 Months · Tots els sexes · Actualitzat el 10 de set. 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Texas Childrens Hospital Houston, Houston
ReclutantFase 1
Edats de 3 anys en endavant · Tots els sexes · Actualitzat el 3 de set. 2026 · NCT06555419Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
- Texas Children's Hospital, Houston
Reclutant
Edats de 3 anys en endavant · Tots els sexes · Actualitzat el 19 d’ag. 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
- Neurology Rare Disease Center, Flower Mound
ReclutantFase 3
0 Days – 42 Days · Tots els sexes · Actualitzat el 18 d’ag. 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Neurology Rare Disease Center, Flower Mound
ReclutantFase 3
0 Days – 7 Months · Tots els sexes · Actualitzat el 11 d’ag. 2026 · NCT07444450Clinical Procedures to Support Research in ALS
- University of Texas San Antonio Health Science Center, San Antonio
ReclutantEstudi observacional
Edats de 18 anys en endavant · Tots els sexes · Actualitzat el 15 de juny 2026 · NCT03489278Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Cook Children's, Fort Worth
- Texas Children's Hospital, Houston
- CHRISTUS Health, San Antonio
ReclutantEstudi observacional
Totes les edats · Tots els sexes · Actualitzat el 31 de gen. 2025 · NCT04174157De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.